Skip to main content

Table 2 Time intervals recorded in the chest pain center

From: Efficacy and safety of intracoronary pro-urokinase combined with low-pressure balloon pre-dilatation during percutaneous coronary intervention in patients with anterior ST-segment elevation myocardial infarction

Time Delay (min)

Intracoronary pro-UK (n = 89)

Intracoronary pro-UK combined with pre-dilatation (n = 90)

P Value

Symptom onset to first medical contact

205 (115–399)

213 (109–411)

0.718

Symptom onset to arterial sheath insertion

246 (154–441)

247 (144–440)

0.904

Symptom onset to randomization by CAG

249 (158–447)

251 (148–445)

0.866

Symptom onset to wiring of culprit vessel

255 (162–459)

257 (155–452)

0.797

Symptom onset to low-pressure balloon pre-dilatation

-

258 (158–459)

-

Symptom onset to intracoronary pro-urokinase

257 (166–463)

261 (161–462)

0.823

Symptom onset to conventional PTCA

261 (170–467)

264 (164–465)

0.742

Symptom onset to provisional stent

266 (174–472)

271 (169–472)

0.831

Interval between wiring of culprit vessel and intracoronary pro-urokinase, median (IQR), min

3.5 (2.2–4.3)

3.8 (2.0–4.0)

0.691